Finance
ScinoPharm reports active pharmaceutical ingredient sales of US$31 million in 2005
Published in Medical Letter on the CDC and FDA, February 26th, 2006
A number of biotech companies are collaborating with ScinoPharm on new drug development. So far, more than 40 new chemical entity (NCE) projects have been executed, with five of them in the phase III stage of clinical trials. Among the NCE projects, one has been commercialized and one customer listed ScinoPharm as the only supplier in its new drug application (NDA). A second API for NCE projects is expected to be introduced in a year.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Antimicrobials
Antimicrobial resistance trends in health care facilities - Drug Safety
Internet pharmaceutical products fall short of U.S. standards - Epidemiology
Report summarizes surveillance of rabies in U.S. during 2004 - Food Safety
Tetrachlorodibenzo-p-dioxin was found in baby food made from chicken fed ball clay - Obesity Surgery
Costs and complications of weight loss surgery are focus of review - Acute Peripheral Arterial Occlusion
Alfimeprase receives U.S. FDA fast track status for acute peripheral arterial occlusion - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
